Acute skin and soft tissue infections are among the most frequent infections in medicine. There is a broad spectrum including simple local infections as well as severe and life-threatening diseases. Along with Staphylococcus aureus, group A Streptococci are mainly responsible for these illnesses. The therapeutic approach ranges from antiseptic local treatments to administering systemic antibiotics or emergency surgery. Treating physicians often face challenges when presented with soft tissue infections due to a great discrepancy between the first impression of the disease compared to a possibly quick progression as well as the wide range of sometimes confusing historic terms and definitions being used in the English and German language, for instance pyoderma, erysipelas or phlegmon. A recently more popular collective term emphasized by clinical trials is "acute bacterial skin and skin structure infections" (ABSSSI).
Keyphrases
- soft tissue
- staphylococcus aureus
- clinical trial
- liver failure
- emergency department
- minimally invasive
- drug induced
- healthcare
- autism spectrum disorder
- randomized controlled trial
- respiratory failure
- escherichia coli
- wound healing
- pseudomonas aeruginosa
- methicillin resistant staphylococcus aureus
- phase ii
- phase iii
- preterm birth